![A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug–Drug Interactions | SpringerLink A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug–Drug Interactions | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40262-019-00856-z/MediaObjects/40262_2019_856_Fig6_HTML.png)
A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug–Drug Interactions | SpringerLink
A physiologically based pharmacokinetic model of voriconazole integrating time-dependent inhibition of CYP3A4, genetic polymorph
![Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections | Future Microbiology Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections | Future Microbiology](https://www.futuremedicine.com/cms/10.2217/17460913.1.4.365/asset/images/medium/graphic35.gif)
Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections | Future Microbiology
![A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug–Drug Interactions | SpringerLink A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug–Drug Interactions | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40262-019-00856-z/MediaObjects/40262_2019_856_Fig3a_HTML.png)
A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug–Drug Interactions | SpringerLink
![Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration - Purkins - 2003 - British Journal of Clinical Pharmacology - Wiley Online Library Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration - Purkins - 2003 - British Journal of Clinical Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/a269fef7-d753-40b1-bbe2-86e0a18f85f0/bcp_1997_f1.gif)
Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration - Purkins - 2003 - British Journal of Clinical Pharmacology - Wiley Online Library
![Pharmaceutics | Free Full-Text | Physiologically Based Pharmacokinetic Modeling of Bupropion and Its Metabolites in a CYP2B6 Drug-Drug-Gene Interaction Network Pharmaceutics | Free Full-Text | Physiologically Based Pharmacokinetic Modeling of Bupropion and Its Metabolites in a CYP2B6 Drug-Drug-Gene Interaction Network](https://www.mdpi.com/pharmaceutics/pharmaceutics-13-00331/article_deploy/html/images/pharmaceutics-13-00331-g001.png)
Pharmaceutics | Free Full-Text | Physiologically Based Pharmacokinetic Modeling of Bupropion and Its Metabolites in a CYP2B6 Drug-Drug-Gene Interaction Network
![A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug–Drug Interactions | SpringerLink A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug–Drug Interactions | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40262-019-00856-z/MediaObjects/40262_2019_856_Fig7_HTML.png)
A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug–Drug Interactions | SpringerLink
![Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients - Vanhove - 2017 - American Journal of Transplantation - Wiley Online Library Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients - Vanhove - 2017 - American Journal of Transplantation - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/007911a7-6e07-4d4b-aa0e-0e46be60592f/ajt14232-fig-0001-m.jpg)
Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients - Vanhove - 2017 - American Journal of Transplantation - Wiley Online Library
![A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug–Drug Interactions | SpringerLink A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug–Drug Interactions | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40262-019-00856-z/MediaObjects/40262_2019_856_Fig1_HTML.png)